Evaluation of the Efficacy and Safety of Adebrelimab Combined With SOX as Adjuvant Therapy for IIIB and IIIC Gastric Cancer
NCT07033143
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cance
Interventions
DRUG:
Adebrelimab+SOX
Sponsor
Tianjin Medical University Cancer Institute and Hospital